Cancel

Request a live demo presentation

One of our sales representative will call you soon


By submitting this form you are acknowledging that you have read and understood our Privacy Policy.

We have generated thousand of leads for our happy customers

  • company
  • company
  • company
  • company
  • company
  • company
  • company
  • company

SHIRE PHARMACEUTICAL DEVELOPMENT LIMITED Active

Scientific & Education


Contact information


This information is available only for subscribed users

Subscribe

Financial statements of SHIRE PHARMACEUTICAL DEVELOPMENT LIMITED

According to SHIRE PHARMACEUTICAL DEVELOPMENT LIMITED latest financial report submitted on 2021-03-31, the company has a Turnover of £10M, Total-Assets of £225M while the Working-Capital is £190M. Compared with the previous year, the company reported a Turnover decrease of -483.59%, which is an equivalent of 47.8 million. At the same time, the Total-Assets went up by 0.77%, or by -1746000.



Consolidated A/cs

For more information you can

Upgrade plan

Turnover 2021

£ 9.9 million

  • Consolidated A/cs

    N

  • Reporting period

    12

  • Working Capital

    £ 190.1 million

  • Profit after Tax

    £ 2.8 million

Reporting period Full financial info

SHIRE PHARMACEUTICAL DEVELOPMENT LIMITED Business Credit Report

A Business Credit Report for SHIRE PHARMACEUTICAL DEVELOPMENT LIMITED is available for instant download. The report will provide you with a credit score and credit limit recommendation for SHIRE PHARMACEUTICAL DEVELOPMENT LIMITED, payment trends, if the company pays their Invoices on time, whether or not the company has any court judgements, ownership and group structure, up to 5 years of financial statements and much more. When you buy a Credit Report from Global Database, you will also have a 7 days free trial to our B2B Sales Platform.


Overall Credit Risk for

SHIRE PHARMACEUTICAL DEVELOPMENT LIMITED

Unlock Credit Report

For more information you can

Key features

  • Credit Score and Credit Limit
  • Financial accounts for the past 5 years
  • Credit Officers
  • Document Filing history
  • Corporate Ownership
  • Outstanding & Satisfied Mortgages
  • Shareholder Information
  • Company Identity

SHIRE PHARMACEUTICAL DEVELOPMENT LIMITED Directors and key executives

View all employees

SHIRE PHARMACEUTICAL DEVELOPMENT LIMITED currently employs 5 people. Compared with the previous year, the company has reported a staff decrease of 92%, which is an equivalent of 59 employees.
In order to view contact information, including emails and phone numbers for all the employees working at SHIRE PHARMACEUTICAL DEVELOPMENT LIMITED and to export them in XL or to your existing CRM, you can subscribe to our platform here.


Total Employee Count

Total employees

5

8%

1y growth

125%

2y growth

Management Level


100

Middle

×
Employee Job Title Email Phone Country
Mark Gibbons Director
-
- GB
Marc Page Director
-
- GB
Kentaro Shirahata Director
-
- GB
Peter Grubin Director
-
- GB

Get in touch with 4 of contacts working at SHIRE PHARMACEUTICAL DEVELOPMENT LIMITED

Upgrade to subscription

SHIRE PHARMACEUTICAL DEVELOPMENT LIMITED Ownership and Group Structure

View full group structure

SHIRE PHARMACEUTICAL DEVELOPMENT LIMITED is a subsidiary of SHIRE PHARMACE************* which holding company is TAKEDA PHARMACEUT****************, with the following registration number 02486738. The holding group consists of a total of 63 companies, including SHIRE INTELLECTUAL PRO*********************, SHIRE HOLDINGS IREL*****************, NPS PHARMA INTERN***************, SHIRE PHARMACEUTICAL INVESTM***************************, SHIRE IRELAND P*************.


SHIRE PHARMACEUTICAL DEVELOPMENT LIMITED Shareholders

View all shareholders

There are currently 1 people with significant control at SHIRE PHARMACEUTICAL DEVELOPMENT LIMITED. One of of major shareholders of SHIRE PHARMACEUTICAL DEVELOPMENT LIMITED is SHIRE PHARMACEUTICALS GROUP, which owns 230610990 ORDINARY shares, with a total value of 230,610,990 GBP.


Name Quantity Share Type Value
SHIRE PHARMACEUTICALS GROUP 230610990 ORDINARY 230610990 GBP

SHIRE PHARMACEUTICAL DEVELOPMENT LIMITED competitors:

View all competitors

Top 5 similar companies of SHIRE PHARMACEUTICAL DEVELOPMENT LIMITED are INNOVATIVE TECHNOLOGY LIMITED, SAC COMMERCIAL LIMITED, TOSHIBA EUROPE LIMITED, GAFFNEY, CLINE & ASSOCIATES LIMITED, MUNDIPHARMA RESEARCH LIMITED. View and export all the competitor list of SHIRE PHARMACEUTICAL DEVELOPMENT LIMITED by upgrading your account here.


INNOVATIVE TECHNOLOGY LIMITED


Revenue
22,176,000.0
Age
37 years
Employees
183
Industry
View Scientific & Education
Website
View http://innovative-****************

SAC COMMERCIAL LIMITED


Revenue
24,893,000.0
Age
28 years
Employees
2
Industry
View Scientific & Education
Website
View http://sr********

TOSHIBA EUROPE LIMITED


Revenue
35,961,795.0
Age
32 years
Employees
137
Industry
View Research
Website
View www.toshi********

GAFFNEY, CLINE & ASSOCIATES LIMITED


Revenue
11,636,000.0
Age
49 years
Employees
40
Industry
View Scientific & Education
Website
View www.gaffney**********

MUNDIPHARMA RESEARCH LIMITED


Revenue
50,908,000.0
Age
20 years
Employees
52
Industry
View Scientific & Education
Website
View www.mundiph**********

SHIRE PHARMACEUTICAL DEVELOPMENT LIMITED news & activities:

View full activity

Turnover

SHIRE PHARMACEUTICAL DEVELOPMENT LIMITED has submitted new account statements and has reported a turnover of £10M, a -483.59% increase year-over-year.

uk.globaldatabase.com

2021-03-31

EBITDA

The SHIRE PHARMACEUTICAL DEVELOPMENT LIMITED-based company said the adjusted EBITDA is now £300,000.00, compared with the previous year of -2478000.

uk.globaldatabase.com

2021-03-31

Employees

SHIRE PHARMACEUTICAL DEVELOPMENT LIMITED number of employees has decreased by -92% compared with previous year and now represents a total number of 5.

uk.globaldatabase.com

2021-03-31

Frequently Asked Questions regarding SHIRE PHARMACEUTICAL DEVELOPMENT LIMITED


Where is SHIRE PHARMACEUTICAL DEVELOPMENT LIMITED registered office?

SHIRE PHARMACEUTICAL DEVELOPMENT LIMITED is located at 1 KINGDOM STREET LONDON, United Kingdom.

What is the website of SHIRE PHARMACEUTICAL DEVELOPMENT LIMITED?

SHIRE PHARMACEUTICAL DEVELOPMENT LIMITED website is http://shire.com

How many people work at SHIRE PHARMACEUTICAL DEVELOPMENT LIMITED?

According to the latest account statement, there are currently 5 of employees working for SHIRE PHARMACEUTICAL DEVELOPMENT LIMITED.

How much revenue does SHIRE PHARMACEUTICAL DEVELOPMENT LIMITED make?

Based on the latest financial accounts submitted on 2021-03-31, the company made £10M for 2021, which went down by -483.59%.

What is SHIRE PHARMACEUTICAL DEVELOPMENT LIMITED EBITDA?

For 2021, SHIRE PHARMACEUTICAL DEVELOPMENT LIMITED has reported an EBITDA of £300,000.00, which went down by -926.0% compared to previous year.

What is the Business Credit Score of SHIRE PHARMACEUTICAL DEVELOPMENT LIMITED and how reliable is the company?

In order to check the business credit score of SHIRE PHARMACEUTICAL DEVELOPMENT LIMITED, you can request a credit report. You will view the latest credit limit information, ownership, group structure, court judgements and much more.

Does SHIRE PHARMACEUTICAL DEVELOPMENT LIMITED pay their invoices on time?

By requesting a Business Credit Report for SHIRE PHARMACEUTICAL DEVELOPMENT LIMITED, you will be able to gain more insights about the SHIRE PHARMACEUTICAL DEVELOPMENT LIMITED payment trends.

Who is the Ultimate Parent of the SHIRE PHARMACEUTICAL DEVELOPMENT LIMITED?

Information about the ultimate beneficial ownership TAKEDA PHARMACEUT**************** of SHIRE PHARMACEUTICAL DEVELOPMENT LIMITED is available when you order a business credit report.

Search for International Credit Report

0 results
Name
Arrow Arrow
City
Arrow Arrow
Address
Arrow Arrow
Reg. No
Arrow Arrow
Status
Arrow Arrow
Action